Cost-effectiveness of treating nicotine dependence: The mayo clinic experience

Ivana T Croghan, Kenneth P. Offord, Roger W. Evans, Silke Schmidt, Leigh C. Gomez-üahl, Darrell R. Schroeder, Christi Ann Patten, Richard D. Hurt

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Objective: To estimate the cost-effectiveness of treating nicotine dependence, expressed as cost per net year of life gained by smoking cessation. Design: A cost-effectiveness analysis was conducted of a cohort of consecutive adult patients treated for nicotine dependence from April 1988 through December 1992 at the Mayo Clinic Nicotine Dependence Center (NDC). Material and Methods: The study cohort consisted of 5,544 patients (50.8% female; mean age, 47.8 years) with a mean baseline smoking rate of 25.4 cigarettes per day. After an initial consultation, a nonphysician counselor developed an individual nicotine dependence treatment plan, which could include follow-up counseling, nicotine replacement therapy (patches or gum), group therapy, or an inpatient program. A relapse-prevention program included telephone calls and a series of letters to the patient. We computed the years of life gained for each person specific to age, gender, smoking rate at entry, and 6-month smoking status by using published mortality rates for current and former cigarette smokers. The 6-month smoking status was assumed to be applicable at 1 year. For subsequent determinations, we modeled by computer simulation the year-by-year (to age 100) smoking status by using published relapse and late cessation rates. Coupled with treatment costs, this information allowed the expression of cost per net year of life gained by stopping smoking. Net years of life gained, discounted 0, 3, and 5%, were computed with use of cessation and relapse rates expected for patients not seen in the NDC. Treatment costs were based on 1993 rates for the intervention services but did not include any tobacco product cost savings associated with smoking cessation. Results: The 1-year smoking-cessation rate was 22.2%. With all NDC patients included, the estimated net years of life gained, with use of a 5% rate of discount for benefits, was 0.058, and the corresponding cost was $6,828 per net year of life gained. Conclusion: In comparison with the cost-effectiveness of other medical services, the cost of $6,828 per net year of life gained by treatment of nicotine dependence is relatively inexpensive. Such cost-outcome data are important as economic considerations are applied for optimal allocation of limited health-care resources. Nonphysician health-care professionals can assume a key role in the provision of cost-effective nicotine dependence intervention.

Original languageEnglish (US)
Pages (from-to)917-924
Number of pages8
JournalMayo Clinic Proceedings
Volume72
Issue number10
StatePublished - 1997

Fingerprint

Tobacco Use Disorder
Cost-Benefit Analysis
Smoking
Costs and Cost Analysis
Smoking Cessation
Tobacco Products
Health Care Costs
Delivery of Health Care
Recurrence
Cost Savings
Health Resources
Gingiva
Group Psychotherapy
Secondary Prevention
Nicotine
Telephone
Computer Simulation
Counseling
Inpatients
Cohort Studies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Croghan, I. T., Offord, K. P., Evans, R. W., Schmidt, S., Gomez-üahl, L. C., Schroeder, D. R., ... Hurt, R. D. (1997). Cost-effectiveness of treating nicotine dependence: The mayo clinic experience. Mayo Clinic Proceedings, 72(10), 917-924.

Cost-effectiveness of treating nicotine dependence : The mayo clinic experience. / Croghan, Ivana T; Offord, Kenneth P.; Evans, Roger W.; Schmidt, Silke; Gomez-üahl, Leigh C.; Schroeder, Darrell R.; Patten, Christi Ann; Hurt, Richard D.

In: Mayo Clinic Proceedings, Vol. 72, No. 10, 1997, p. 917-924.

Research output: Contribution to journalArticle

Croghan, IT, Offord, KP, Evans, RW, Schmidt, S, Gomez-üahl, LC, Schroeder, DR, Patten, CA & Hurt, RD 1997, 'Cost-effectiveness of treating nicotine dependence: The mayo clinic experience', Mayo Clinic Proceedings, vol. 72, no. 10, pp. 917-924.
Croghan IT, Offord KP, Evans RW, Schmidt S, Gomez-üahl LC, Schroeder DR et al. Cost-effectiveness of treating nicotine dependence: The mayo clinic experience. Mayo Clinic Proceedings. 1997;72(10):917-924.
Croghan, Ivana T ; Offord, Kenneth P. ; Evans, Roger W. ; Schmidt, Silke ; Gomez-üahl, Leigh C. ; Schroeder, Darrell R. ; Patten, Christi Ann ; Hurt, Richard D. / Cost-effectiveness of treating nicotine dependence : The mayo clinic experience. In: Mayo Clinic Proceedings. 1997 ; Vol. 72, No. 10. pp. 917-924.
@article{4f4e6c1b9a0348a7bc25058ab4d01831,
title = "Cost-effectiveness of treating nicotine dependence: The mayo clinic experience",
abstract = "Objective: To estimate the cost-effectiveness of treating nicotine dependence, expressed as cost per net year of life gained by smoking cessation. Design: A cost-effectiveness analysis was conducted of a cohort of consecutive adult patients treated for nicotine dependence from April 1988 through December 1992 at the Mayo Clinic Nicotine Dependence Center (NDC). Material and Methods: The study cohort consisted of 5,544 patients (50.8{\%} female; mean age, 47.8 years) with a mean baseline smoking rate of 25.4 cigarettes per day. After an initial consultation, a nonphysician counselor developed an individual nicotine dependence treatment plan, which could include follow-up counseling, nicotine replacement therapy (patches or gum), group therapy, or an inpatient program. A relapse-prevention program included telephone calls and a series of letters to the patient. We computed the years of life gained for each person specific to age, gender, smoking rate at entry, and 6-month smoking status by using published mortality rates for current and former cigarette smokers. The 6-month smoking status was assumed to be applicable at 1 year. For subsequent determinations, we modeled by computer simulation the year-by-year (to age 100) smoking status by using published relapse and late cessation rates. Coupled with treatment costs, this information allowed the expression of cost per net year of life gained by stopping smoking. Net years of life gained, discounted 0, 3, and 5{\%}, were computed with use of cessation and relapse rates expected for patients not seen in the NDC. Treatment costs were based on 1993 rates for the intervention services but did not include any tobacco product cost savings associated with smoking cessation. Results: The 1-year smoking-cessation rate was 22.2{\%}. With all NDC patients included, the estimated net years of life gained, with use of a 5{\%} rate of discount for benefits, was 0.058, and the corresponding cost was $6,828 per net year of life gained. Conclusion: In comparison with the cost-effectiveness of other medical services, the cost of $6,828 per net year of life gained by treatment of nicotine dependence is relatively inexpensive. Such cost-outcome data are important as economic considerations are applied for optimal allocation of limited health-care resources. Nonphysician health-care professionals can assume a key role in the provision of cost-effective nicotine dependence intervention.",
author = "Croghan, {Ivana T} and Offord, {Kenneth P.} and Evans, {Roger W.} and Silke Schmidt and Gomez-{\"u}ahl, {Leigh C.} and Schroeder, {Darrell R.} and Patten, {Christi Ann} and Hurt, {Richard D.}",
year = "1997",
language = "English (US)",
volume = "72",
pages = "917--924",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "10",

}

TY - JOUR

T1 - Cost-effectiveness of treating nicotine dependence

T2 - The mayo clinic experience

AU - Croghan, Ivana T

AU - Offord, Kenneth P.

AU - Evans, Roger W.

AU - Schmidt, Silke

AU - Gomez-üahl, Leigh C.

AU - Schroeder, Darrell R.

AU - Patten, Christi Ann

AU - Hurt, Richard D.

PY - 1997

Y1 - 1997

N2 - Objective: To estimate the cost-effectiveness of treating nicotine dependence, expressed as cost per net year of life gained by smoking cessation. Design: A cost-effectiveness analysis was conducted of a cohort of consecutive adult patients treated for nicotine dependence from April 1988 through December 1992 at the Mayo Clinic Nicotine Dependence Center (NDC). Material and Methods: The study cohort consisted of 5,544 patients (50.8% female; mean age, 47.8 years) with a mean baseline smoking rate of 25.4 cigarettes per day. After an initial consultation, a nonphysician counselor developed an individual nicotine dependence treatment plan, which could include follow-up counseling, nicotine replacement therapy (patches or gum), group therapy, or an inpatient program. A relapse-prevention program included telephone calls and a series of letters to the patient. We computed the years of life gained for each person specific to age, gender, smoking rate at entry, and 6-month smoking status by using published mortality rates for current and former cigarette smokers. The 6-month smoking status was assumed to be applicable at 1 year. For subsequent determinations, we modeled by computer simulation the year-by-year (to age 100) smoking status by using published relapse and late cessation rates. Coupled with treatment costs, this information allowed the expression of cost per net year of life gained by stopping smoking. Net years of life gained, discounted 0, 3, and 5%, were computed with use of cessation and relapse rates expected for patients not seen in the NDC. Treatment costs were based on 1993 rates for the intervention services but did not include any tobacco product cost savings associated with smoking cessation. Results: The 1-year smoking-cessation rate was 22.2%. With all NDC patients included, the estimated net years of life gained, with use of a 5% rate of discount for benefits, was 0.058, and the corresponding cost was $6,828 per net year of life gained. Conclusion: In comparison with the cost-effectiveness of other medical services, the cost of $6,828 per net year of life gained by treatment of nicotine dependence is relatively inexpensive. Such cost-outcome data are important as economic considerations are applied for optimal allocation of limited health-care resources. Nonphysician health-care professionals can assume a key role in the provision of cost-effective nicotine dependence intervention.

AB - Objective: To estimate the cost-effectiveness of treating nicotine dependence, expressed as cost per net year of life gained by smoking cessation. Design: A cost-effectiveness analysis was conducted of a cohort of consecutive adult patients treated for nicotine dependence from April 1988 through December 1992 at the Mayo Clinic Nicotine Dependence Center (NDC). Material and Methods: The study cohort consisted of 5,544 patients (50.8% female; mean age, 47.8 years) with a mean baseline smoking rate of 25.4 cigarettes per day. After an initial consultation, a nonphysician counselor developed an individual nicotine dependence treatment plan, which could include follow-up counseling, nicotine replacement therapy (patches or gum), group therapy, or an inpatient program. A relapse-prevention program included telephone calls and a series of letters to the patient. We computed the years of life gained for each person specific to age, gender, smoking rate at entry, and 6-month smoking status by using published mortality rates for current and former cigarette smokers. The 6-month smoking status was assumed to be applicable at 1 year. For subsequent determinations, we modeled by computer simulation the year-by-year (to age 100) smoking status by using published relapse and late cessation rates. Coupled with treatment costs, this information allowed the expression of cost per net year of life gained by stopping smoking. Net years of life gained, discounted 0, 3, and 5%, were computed with use of cessation and relapse rates expected for patients not seen in the NDC. Treatment costs were based on 1993 rates for the intervention services but did not include any tobacco product cost savings associated with smoking cessation. Results: The 1-year smoking-cessation rate was 22.2%. With all NDC patients included, the estimated net years of life gained, with use of a 5% rate of discount for benefits, was 0.058, and the corresponding cost was $6,828 per net year of life gained. Conclusion: In comparison with the cost-effectiveness of other medical services, the cost of $6,828 per net year of life gained by treatment of nicotine dependence is relatively inexpensive. Such cost-outcome data are important as economic considerations are applied for optimal allocation of limited health-care resources. Nonphysician health-care professionals can assume a key role in the provision of cost-effective nicotine dependence intervention.

UR - http://www.scopus.com/inward/record.url?scp=0030777417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030777417&partnerID=8YFLogxK

M3 - Article

C2 - 9379693

AN - SCOPUS:0030777417

VL - 72

SP - 917

EP - 924

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 10

ER -